NCT03381573View on ClinicalTrials.gov

Long-term Observational Study of the Safety of Roflumilast

CompletedOBSERVATIONAL

Enrollment

135,856

Participants

Timeline

Start Date

December 15, 2013

Primary Completion Date

September 16, 2022

Study Completion Date

September 16, 2022

Conditions

COPD

Interventions

DRUG

Roflumilast

Roflumilast

Trial Locations (4)

02139

Research Site, Cambridge

Unknown

Research Site, Bremen

Research Site, Solna

0483

Research Site, Oslo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY